Clinical Trials Sponsored by Vector Oncology

Total 4880 results

Inivata
Vector Oncology

Completed

Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing

Non-Small Cell Lung Cancer

United States
Vector Oncology
Novartis

Completed

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

Liposarcoma | Surgically Unresectable Liposarcoma | Metastatic Liposarcoma

United States
Vector Oncology
GlaxoSmithKline

Completed

Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors

Gynecologic Tumors

United States
Vector Oncology
Eisai Inc.

Terminated

Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer

HER-2 Positive Breast Cancer

United States
Emory University
National Cancer Institute (NCI); West Cancer Center; Vector Oncology

Completed

THRIVE Breast Cancer App Study (THRIVE)

Breast Neoplasm Female

United States
Ventor Technologies

Unknown

Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease

Aortic Valve Disease

Germany
Vektor Medical
Experien Group

Completed

Vektor vMap™ Clinical Validation Study

Atrial Fibrillation | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Arrythmia | Cardiac Arrhythmia | Premature Ventricular Complexes Multiple | Premature Atrial Complex | Atrioventricular Reentrant Tachycardia

United States
Centre Hospitalier Victor Dupouy

Unknown

Qualitative Evaluation of Therapeutic Alliance in Adolescent Psychiatry (EVAADO)

Depression | Anorexia Nervosa | School Phobia

France
Centre Hospitalier Victor Dupouy

Completed

Clinical Evaluation of AutoFlow Mode During Mechanical Ventilation (AFON)

Ventilation, Mechanical

France
Alector Inc.

Completed

A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101

Healthy

United States
Vectura Limited

Completed

A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma Subjects

Asthma

United States
Alector Inc.

Active, not recruiting

A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

Frontotemporal Dementia

Spain, United States, Portugal, United Kingdom, France, Germany, Netherlands, Belgium, Australia, Italy, Turkey, Switzerland, Argentina, Canada, Greece, Sweden
Alector Inc.

Completed

A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation

Healthy | Frontotemporal Dementia

United States, Canada, United Kingdom
Vectura Limited

Completed

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Asthma

United States, Bulgaria, Germany, Hungary, Poland, Romania, Ukraine, United Kingdom
Vectura Limited

Completed

A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy

Cough | Wheezing

United States
Université Victor Segalen Bordeaux 2

Completed

Tracheal Dosage of Amylase : a New Surrogate for Microaspirations in Ventilated ICU Patients

Ventilated-acquired Pneumonia

France
Université Victor Segalen Bordeaux 2

Completed

Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful? (REAMICHOC)

Acute Kidney Injury | Severe Sepsis

France
Hannover Medical School
Hector-Stiftung

Completed

Role of the Autonomic Nervous System in HIV-Lipodystrophy

HIV Infections | Lipodystrophy-Syndrome

Germany
Alector Inc.

Active, not recruiting

A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

Frontotemporal Dementia

Canada, United States, Germany, United Kingdom, Italy, Netherlands
Alector Inc.

Terminated

A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS

Amyotrophic Lateral Sclerosis

United States
Alector Inc.

Completed

First in Human Study for Safety and Tolerability of AL003.

Healthy | Alzheimer Disease

United States, Australia
Alector Inc.

Completed

A Phase I Study for Safety and Tolerability of AL002.

Healthy | Alzheimer Disease

United States, United Kingdom, Australia
Vectura Limited

Completed

Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma

Asthma

United States, Philippines, Poland, Romania, Ukraine
Vectura Limited

Completed

A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma

Wheezing | Reactive Airway Disease | Mild Asthma

United States
Hector Hernandez

Approved for marketing

Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

Total Parenteral Nutrition-induced Cholestasis

United States
Université Victor Segalen Bordeaux 2

Completed

E Test Strips Applied to Bronchoalveolar Lavage for Suspicion of Hospital-acquired Pneumonia to Accelerate Antibiogram Analysis.

Hospital-acquired Pneumonia

France
Université Victor Segalen Bordeaux 2

Completed

Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired Pneumonia

Ventilator Acquired Pneumonia

France
Université Victor Segalen Bordeaux 2

Suspended

Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria

Malaria

Cameroon
UCB S.A. - Pharma Sector

Completed

ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)

Rhinitis, Allergic, Perennial

Italy
UCB S.A. - Pharma Sector

Completed

Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects

Rhinitis, Allergic, Seasonal

Canada
UCB S.A. - Pharma Sector

Terminated

A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke

Acute Ischaemic Middle Cerebral Artery Stroke

Sweden, Argentina, Austria, Belgium, France, Germany, Greece, Hungary, Italy, Norway, Poland, Singapore, Spain, Taiwan, Turkey
GlaxoSmithKline
Alector Inc.

Recruiting

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease (PROGRESS-AD)

Alzheimer's Disease

United States, Australia, France, Italy, Spain, Germany, Norway, Korea, Republic of, Canada, Finland, Sweden, Taiwan, Argentina, Turkey, Netherlands, United Kingdom
Mentor Worldwide, LLC

Active, not recruiting

A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction (Athena)

Breast Reconstruction, Revision Breast Reconstruction

United States
Vertos Medical, Inc.

Active, not recruiting

The MOTION Study - Treatment of LSS With the MILD Procedure

Spinal Stenosis, Lumbar Region, With Neurogenic Claudication

United States
Mentor Worldwide, LLC

Completed

Mentor MemoryGel Post-Approval Study (MGPAS)

Breast Augmentation | Breast Reconstruction | Breast Revision
Mentor Worldwide, LLC

Terminated

Study of the Mentor Becker Expander/Breast Implant in Subjects Who Are Undergoing Primary Breast Reconstruction

Breast Reconstruction
Mentor Worldwide, LLC

Completed

CPG Styles Study: A Study of the Safety of the Contour Profile Gel Breast Implants (CPG Styles Study)

Breast Augmentation | Breast Reconstruction | Breast Revision

United States
Mentor Worldwide, LLC

Approved for marketing

Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant (CPG-CA)

Breast Augmentation | Breast Reconstruction | Breast Revision
Mentor Worldwide, LLC

Approved for marketing

Mentor Adjunct Study for Silicone Gel-Filled Mammary Prosthesis (Adjunct)

Breast Reconstruction

United States
Mentor Worldwide, LLC

Completed

PREVELLE Shape (CX002) Dermal Filler Protocol

Correction of Nasolabial Folds and Lip Augmentation

United States
Alector Inc.
AbbVie

Recruiting

A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease

Alzheimer's Disease

Australia, Spain, United States, Italy, Canada, Poland, United Kingdom, Germany
Mentor Worldwide, LLC

Active, not recruiting

Memory Gel and Shape Combined Cohort (Glow)

Primary Breast Augmentation | Primary Breast Reconstruction | Revision Breast Augmentation | Revision Breast Reconstruction

United States
Vertos Medical, Inc.

Completed

The MiDAS ENCORE Study

Spinal Stenosis, Lumbar Region, With Neurogenic Claudication

United States
Mentor Worldwide, LLC

Completed

Mentor Siltex® Contour Profile Gel Mammary Prosthesis Clinical Trial (CPG)

Breast Augmentation | Breast Reconstruction | Breast Revision

United States
Vertos Medical, Inc.

Completed

MiDAS III (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study (MiDAS III)

Lumbar Spinal Stenosis

United States
Mentor Worldwide, LLC

Completed

Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses

Breast Augmentation | Breast Reconstruction | Breast Revision

United States
Mentor Worldwide, LLC

No longer available

Compassionate Use of the Becker Expander/Breast Implant

Breast Reconstruction

United States
Vertos Medical, Inc.

Completed

MiDAS I (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study (MiDAS I)

Lumbar Spinal Stenosis

United States
Mentor Worldwide, LLC

Withdrawn

Spectra Breast Implant Study

Augmentation | Augmentation Revision | General Breast Enlargement | Post-lactational Involution | Asymmetry

United States
UCB S.A. - Pharma Sector

Completed

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Epilepsy, Partial

United States

Clinical Trials Sponsored by Vector Oncology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations